1. "2020"
Formats
  1. Journal Article (2337)
  2. Meeting Abstract (1901)
  3. Review (494)
  4. Editorial (342)
  5. Correspondence (121)
  6. Guidelines (114)
  7. Book Section (99)
  8. Research Letter (95)
  9. Miscellaneous (61)
  10. Conference Paper (33)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2560)
  2. Solid Tumor Oncology Division (1535)
  3. GSK Faculty (1257)
  4. Sloan Kettering Institute Postdocs (1240)
  5. Hematologic Malignancies, Division of (936)
  6. Survivorship Research (930)

More Groups

People
  1. Jorge Reis-Filho (93)
  2. Miguel-Angel Perales (93)
  3. Sergio Giralt (91)
  4. Alexander Drilon (81)
  5. Britta Weigelt (76)
  6. Nadeem Abu-Rustum (71)

More People

Years
  1. 2020 (5599)
Publications
  1. Journal of Clinical Oncology (500)
  2. Blood (212)
  3. Cancer Research (185)
  4. Annals of Oncology (152)
  5. International Journal of Radiation Oncology, Biology, Physics (129)
  6. Laboratory Investigation (116)

More Publications

Publishers
  1. Elsevier Inc. (714)
  2. American Society of Clinical Oncology (548)
  3. Nature Publishing Group (385)
  4. American Association for Cancer Research (357)
  5. Oxford University Press (356)
  6. Springer (342)

More Publishers

Results (5599)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; Knezevic, A.; Shah, N. J.; Carlo, M. I.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Enrollment barriers of adolescents and young adults (AYA) on the non-chemotherapy arm of ARST1321
    Meeting Abstract

    Kopp, L. M.; Reed, D. R.; Ahmed, S. K.; Allen-Rhoades, W.; Avutu, V.; Chen, Y. L.; Davis, L. E.; Eaton, B. R.; Hawkins, D. S.; Indelicato, D. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Integrated-omics of MRI-visible and -invisible prostate cancer identifies molecular correlations with clinical outcome
    Meeting Abstract

    Kim, E.; Miheecheva, N.; Ramachandran, A.; Lyu, Y.; Galkin, I.; Svekolkin, V.; Postovalova, E.; Bagaev, A.; Nomie, K.; Ogloblina, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid cystic carcinoma
    Meeting Abstract

    Kang, H.; Ho, A. L.; Muzaffar, J.; Bowles, D. W.; Kim, S. B.; Ahn, M. J.; Hanna, G. J.; Worden, F. P.; Yun, T.; Norton, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I study of AMG 509, a STEAP1 x CD3 T cell-recruiting XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Kelly, W. K.; Danila, D. C.; Edenfield, W. J.; Aggarwal, R. R.; Petrylak, D. P.; Sartor, A. O.; Sumey, C. J.; Dorff, T. B.; Yu, E. Y.; Adra, N.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Do differences in the microbiome explain early onset in colon cancer?
    Meeting Abstract

    Keshinro, A.; Vanderbilt, C.; Stadler, Z. K.; Shia, J.; Gonen, M.; Chen, C. T.; Cercek, A.; Mendelsohn, R. B.; Yaeger, R.; Zehir, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Joffe, E.; Vardhana, S. A.; Kumar, A.; Abedi, M.; Hoeg, R.; Sharon, E.; Younes, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Masterkey-01: Phase I/II, open-label multicenter study to assess safety, tolerability, pharmacokinetics, and antitumor activity of BDTX-189, an inhibitor of allosteric ErbB mutations, in patients with advanced solid malignancies
    Meeting Abstract

    Hamilton, E. P.; Patel, M. R.; Rodon, J.; Hong, D. S.; Schram, A. M.; Janne, P. A.; LoRusso, P.; Sachdev, J. C.; Ou, S. H.; Buck, E. A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Growth modulation index (GMI) as a comparative efficacy measure of larotrectinib versus prior systemic treatments for TRK fusion cancer patients
    Meeting Abstract

    Italiano, A.; Hong, D. S.; Briggs, A.; Garcia-Foncillas, J.; Lassen, U. N.; Vassal, G.; Kummar, S.; Van Tilburg, C. M.; Keating, K. N.; Reeves, J. A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Post-transplant lymphoproliferative disorder (PTLD) after solid organ transplant (SOT): A multicenter real world analysis (RWA) of 877 patients (pts) treated in the modern era
    Meeting Abstract

    Jagadeesh, D.; Tsai, D. E.; Wei, W.; Bustamante, J. A.; Wagner-Johnston, N. D.; Berg, S.; Kim, S. H.; Reddy, N. M.; Sriram, D.; Portell, C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save